In soon-to-be published research by Gnosis by Lesaffre, new findings suggest that daily intakes of MenaQ7 vitamin K supplement may improve blood vessel elasticity and regulate blood pressure in menopausal women with arterial stiffness.
A new RCT highlights that following supplementation with vitamin K2 (MK-7) in patients with haemodialysis (HD), there were decreases in measures of arterial stiffness which were more pronounced in those with diabetes, compared to those receiving standard...
A pilot study involving 12 patients with chronic kidney disease suggests supplementation surpasses a vitamin-rich diet in improving vit K levels in individuals who are susceptible to deficiency.
A new study testing a methodology for assessing vitamin supplement content has revealed significant deviations in the content of vitamin K2 and D3 in tested supplements, adding that claims made on the labels may be misleading to consumers.
Novozymes OneHealth will showcase the science supporting the nerve health benefits of its MenaquinGold vitamin K2-7 at the upcoming Expo West trade show in Anaheim, CA on March 9-11.
New York-based Balchem Corporation has signed a definitive agreement to acquire Norwegian Vitamin K2 supplier Kappa Bioscience AS for approximately US$340 million.
A scientist working for Kappa Bioscience discovered the secret of how to produce vitamin K on a large scale after noticing a growing demand for K2 due to its extraordinary health benefits.
Along with developing the science and marketing story behind an ingredient, suppliers also need to ensure those ingredients are easy to work with. A prominent vitamin K2 supplier says it has done just that with a new, stability-enhanced version of...
NattoPharma's research partner has published a study suggesting Vitamin K2 reduces the risk of cadiovascular events in people who smoke, as it decreases oxidative stress and vascular calcification.
Global biotech giant Gnosis by Lesaffre is expanding its capability as a global supplier of vitamin K2 with its acquisition of world leading developer NattoPharma.
Overcoming micronutrient deficiencies could become part of an effective strategy in the fight against COVID-19. While vitamin D supplementation has gained wide attention amid the pandemic, in the shadows is a lesser known but equally important nutrient:...
Norway-based vitamin K2 supplier NattoPharma has highlighted new evidence connecting statin use to increased cardiovascular risk which it says further proves the need for Vitamin K2 supplementation in these patients.
A new study on cardiovascular health using a protein as a biomarker has bolstered the evidence backing the notion that the benefits of vitamin K2 are so important that the substance should have its own RDI, a Norwegian supplier says.
Given the current torrid pace of sales for some categories, the dietary supplement industry could emerge from the present crisis is a significantly strengthened position. Even categories that are in the doldrums stand to benefit.
Many people – and older men in particular – are not getting enough vitamin K, says a new article by Consumer Reports that draws attention to the benefits of the vitamin.
A recent review paper funded by a Norwegian research grant reinforces the developing story that vitamin K2 is important for cardiovascular health as well as bone health.
New research on vitamin K suggests that it may promote eye health, thanks to the vitamin’s link to active matrix Gla protein, or MGP, an inhibitor of calcification in large arteries.
Researchers found that individuals with arterial stiffening have increased risk of dementia, paving a way to market vitamin K2 in the brain health space—an area in which K2 was not previously considered, according to one supplier.
The United Natural Products Alliance, a trade association for the dietary supplement industry, has signed memoranda of understanding agreements with three single-ingredient associations and their administrative umbrella, the Trust Transparency Center.
There has been a ‘disturbing growth’ in the incidence of low-energy bone fractures in healthy children and adolescents, a group of researchers wrote in a new review, arguing that insufficiency of vitamin D, vitamin K, and calcium are among leading considerations.
Four-week supplementation with vitamin K2 MK-7 (menaquinone-7) significantly improves vascular calcification (VC), according to a new study published in BMC Nephrology.
Children with low levels of vitamin K2 are at an increased risk of fractures, and small changes in vitamin K status can have a big effects on bone health, says a new study from Poland.
It’s fitting that a relatively new institution—Maastricht University—is helping to drive research into the evolving benefits of a ‘new’ vitamin, Vitamin K2. That research will be buoyed by a multi-center EU grant announced today.
A lack of an active vitamin K- dependent protein may increase the risk of arterial calcification and stiffness, say two new studies that support the potential heart health benefits of vitamin K.
Increased intakes of long-chain menaquinones (vitamin K2) may reduce the risk of mortality from coronary heart disease (CHD), according to data from the European Prospective Investigation into Cancer and Nutrition (EPIC-NL) cohort.
Over the past five years, new food and beverage product launches containing vitamin K2 have nearly doubled worldwide (up 183%), according to new research from Mintel.
After 18 months, DuPont Nutrition & Health and Kappa Bioscience, are set for a large-scale push of synthetic vitamin K2, which has just been approved as a novel food ingredient in the European Union by German authorities.
A Norwegian ingredient supplier has developed a new form of Vitamin K2, which it says has similar bioavailability to existing forms on the market but is up to 20 per cent cheaper.
The null findings of a randomised clinical trial of vitamin K2 and bone health do not mean the vitamin does not benefit skeletal health, say leading scientists in the field who have challenged the recent findings.
Consuming foods rich in vitamin K2 may reduce the risk of cancer, says a new study supporting the potential anti-cancer benefits of this emerging nutrient.
Supplements of vitamin K2 may improve bone health in people following organ transplants, says a new study that adds to the growing list of benefits of the vitamin.
The formal European Union approval of vitamin K2 as a safe food ingredient in foods and food supplements will benefit Norwegian supplier, Natto Pharma, both in Europe and abroad, the company says.
Vitamin K2 has won Novel Foods approval paving the way for the fermented soy extract to be used in a wide variety of applications across the European Union’s 27 member states.
Danish supplier Danisco BioActives and Norwegian vitamin K specialist, NattoPharma, have inked a deal that will see Danisco become the marketer and distributor of Natto’s vitamin K2 ingredient to the food industry.
PL Thomas is to market its vitamin K2 for use in dairy applications
in the US, following the ingredient's GRAS designation, the company
announced today.
Daily supplements of vitamin K2 maintained hipbone strength in
postmenopausal women, while placebo led to weakening, says a study
from the Netherlands.
Vitamin K2 derived from the fermented soy product natto has a
higher bioavailability than vitamin K1, results that may have
implications for functional food formulators.
The second new source of natural vitamin K2 is announced on the US
market in as many weeks, as Blue California is becomes exclusive
distributor of Vitamin K2-All Trans.
